Compare SPXC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPXC | RGEN |
|---|---|---|
| Founded | 1912 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.0B |
| IPO Year | 1994 | 1995 |
| Metric | SPXC | RGEN |
|---|---|---|
| Price | $168.58 | $163.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 22 |
| Target Price | ★ $257.36 | $196.70 |
| AVG Volume (30 Days) | 580.9K | ★ 1.1M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.08 | ★ 286.96 |
| EPS | ★ 2.73 | 0.24 |
| Revenue | ★ $2,265,100,000.00 | $141,236,000.00 |
| Revenue This Year | $21.71 | $12.02 |
| Revenue Next Year | $13.08 | $18.03 |
| P/E Ratio | ★ $62.51 | $701.19 |
| Revenue Growth | 14.17 | ★ 35.10 |
| 52 Week Low | $166.17 | $100.99 |
| 52 Week High | $251.08 | $198.87 |
| Indicator | SPXC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.64 | 39.68 |
| Support Level | N/A | $159.22 |
| Resistance Level | $247.47 | $175.32 |
| Average True Range (ATR) | 5.31 | 8.95 |
| MACD | 0.66 | -3.00 |
| Stochastic Oscillator | 11.99 | 11.84 |
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.